CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822844431
- Phone
- 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-24 | Big Rock Partners Sponsor, LLC 10% owner | Conversion · Rights, exchangeable for Common Stock | −272,500 | 0 | ||
| 2021-05-24 | Big Rock Partners Sponsor, LLC 10% owner | Purchase · Unit Purchase Option | +100,000 | $1.00 | $100K | 100,000 |
| 2021-05-24 | BRAC Lending Group LLC 10% owner | Returned to the company | −869,565 | 562,435 | ||
| 2020-03-13 | Polar Asset Management Partners Inc. 10% owner | Sale | −29,464 | $10.60 | $312K | 488,036 |
| 2018-11-20 | ACKERMAN RICHARD President and CEO | Sale | −1,500,000 | 225,000 | ||
| 2017-11-29 | ACKERMAN RICHARD President and CEO | Purchase | +22,500 | $10.00 | $225K | 272,500 |
| 2017-11-29 | ACKERMAN RICHARD President and CEO | Purchase · Right to receive common stock | +22,500 | 27,250 | ||
| 2017-11-29 | ACKERMAN RICHARD President and CEO | Purchase · Warrant | +11,250 | 136,250 |
Page 6 of 6 · 108 trades